Chemours Company (the) · NYSE:CC

Chemours Company (the) — The Chemours Company — Q3 2017 Earnings Presentation

16 slides from Chemours Company (the)'s earnings presentation, Nov 3, 2017

  1. Slide 1: The Chemours Company Third Quarter Earnings Presentation

    The Chemours Company Third Quarter Earnings Presentation November 3, 2017

  2. Slide 2: Safe Harbor Statement and Other Matters

    Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Forward-looking statements provide current expectations

  3. Slide 3: Third Quarter 2017 Highlights

    Third Quarter 2017 Highlights Strong year-over-year performance with improvement across all key financial metrics Strengthened demand for Ti-Pure™ TiO2 paired with favorable pricing actions Increased Opteon™ refrigerant sales and solid demand for fluoropolymers products Reaffirmed full-year 2017 Adj

  4. Slide 4: 3Q17 Overview: Third Quarter Financial Summary

    3Q17 Overview ($ in millions, except per share statistics, unless otherwise noted) Third Quarter Financial Summary ∆ Year-Over-Year 3Q17 3Q16 Yr/Yr  Results primarily driven by increased sales of Ti-Pure™ Net Sales $1,584 $1,398 $186 titanium dioxide Net Income1 207 204 3  Adjusted EBITDA margin A

  5. Slide 5: Adjusted EBITDA Bridge: 3Q17 versus 3Q16

    Adjusted EBITDA Bridge: 3Q17 versus 3Q16 Positive Impact ($ in millions) • Strong volume growth for Opteon™ refrigerants Negative Impact • Increased demand for fluoropolymer products • Solid demand for Ti-Pure™ titanium dioxide $59 ($91) - $135 • Higher variable and - distribution costs • Higher leg

  6. Slide 6: Liquidity Position

    Liquidity Position ($ in millions) $20 Negative Impact Positive Impact  Free Cash Flow of $324M1 versus $65 $131M in 3Q16 ($180)  Cash position unchanged after $207 completing our portion of PFOA ($108) settlement payment during the $7 quarter ($5)  Working capital release of $140M, excluding PFO

  7. Slide 7: Titanium Technologies Business Summary

    Titanium Technologies Business Summary Third Quarter Highlights Outlook Commentary  Communicated price increases through  Full-year volume anticipated to increase by customer letters during the quarter; price high single-digits percentage year-over-year increases vary by application, grade and end

  8. Slide 8: Fluoroproducts Business Summary

    Fluoroproducts Business Summary Third Quarter Highlights Outlook Commentary  Opteon™ refrigerant revenue up approximately  Nearing one year anniversary of EU MAC 50% compared to very strong third quarter in directive; US adoption pace on target the previous year driven by EU MAC directive  HFO-ba

  9. Slide 9: Chemical Solutions Business Summary

    Chemical Solutions Business Summary Third Quarter Highlights Outlook Commentary  Volume increase due to higher demand for  Demand for Mining Solutions anticipated to Mining Solutions and Performance Chemicals remain strong & Intermediates products  Mining Solutions annual planned maintenance  Hi

  10. Slide 10: 2017 Outlook Reaffirmed

    2017 Outlook Reaffirmed 2017 Adjusted EBITDA Expected To Be Between $1.3 - $1.4 Billion With Positive Free Cash Flow1 Key Factors Influencing Market Performance Market Factors Chemours Initiatives • TiO2 price • Cost reductions • Currency • Altamira expansion ramp-up • End-market demand • Opteon™ ma

  11. Slide 11: Appendix

    Appendix

  12. Slide 12: GAAP Net Income to Adjusted Net Income and Adjusted EBITDA Reconciliations

    GAAP Net Income to Adjusted Net Income and Adjusted EBITDA Reconciliations GAAP Net Income to Adjusted Net Income and Adjusted EBITDA Tabular Reconciliations ($ in millions except per share amounts) Three months ended Three months ended September 30, June 30, 2017 2016 2017 $ amounts $ per share $ a

  13. Slide 13: Free Cash Flow Reconciliation

    Free Cash Flow Reconciliation GAAP Cash Flow to Free Cash Flow Tabular Reconciliations ($ in millions unless otherwise noted) Three months ended Nine months ended September 30, June 30, September 30, 2017 2016 2017 2017 2016 Cash flow provided by operating activities 1 2 $ 112 $ 198 $ 183 $ 336 $ 32

  14. Slide 14: Segment Net Sales and Adjusted EBITDA (unaudited)

    Segment Net Sales and Adjusted EBITDA (unaudited) SEGMENT NET SALES AND ADJUSTED EBITDA (UNAUDITED) ($ in millions unless otherwise noted) Three months ended Three months ended September 30, June 30, 2017 2016 2017 SEGMENT NET SALES Titanium Technologies $ 799 $ 625 $ 729 Fluoroproducts 637 591 710

  15. Slide 15: Reconciliation of Outlook

    Reconciliation of Outlook 2017 Estimated GAAP Net Income to Estimated Adjusted EBITDA Tabular Reconciliation (UNAUDITED) ($ in millions unless otherwise noted) Estimated Net Income 1 $605 - 680 Provision for income taxes 1 2 195 - 220 Interest expense, net ~ 220 Depreciation and amortization ~ 280 O

  16. Slide 16: ©2017 The Chemours Company. Chemours™ and the Chemours Logo are trademarks or registered trademarks

    ©2017 The Chemours Company. Chemours™ and the Chemours Logo are trademarks or registered trademarks of The Chemours Company 15

The Chemours Company — Q3 2017 Earnings Presentation on 6ix